lobbying_activities: 1225830
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1225830 | 94d984ab-b0a2-416c-a538-4cb6f7753a35 | Q1 | DALRYMPLE & ASSOCIATES, LLC | 5073 | EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) | 2012 | first_quarter | HOM | Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 46000 | 0 | 0 | 2012-04-12T15:32:57.997000-04:00 |